TY - JOUR
T1 - A functional genomics pipeline to identify high-value asthma and allergy CpGs in the human methylome
AU - program collaborators for Environmental Influences on Child Health Outcomes and Children's Respiratory and Environmental Workgroup
AU - Morin, Andréanne
AU - Thompson, Emma E.
AU - Helling, Britney A.
AU - Shorey-Kendrick, Lyndsey E.
AU - Faber, Pieter
AU - Gebretsadik, Tebeb
AU - Bacharier, Leonard
AU - Kattan, Meyer
AU - O'Connor, George T.
AU - Rivera-Spoljaric, Katherine
AU - Wood, Robert A.
AU - Barnes, Kathleen C.
AU - Mathias, Rasika A.
AU - Altman, Matthew C.
AU - Hansen, Kasper
AU - McEvoy, Cindy T.
AU - Spindel, Eliot R.
AU - Hartert, Tina
AU - Jackson, Daniel J.
AU - Gern, James E.
AU - McKennan, Chris G.
AU - Ober, Carole
N1 - Funding Information:
Research reported in this publication was supported by the Environmental influences on Child Health Outcomes (ECHO) program, Office of the Director , National Institutes of Health , under awards U2COD023375 (Coordinating Center), U24OD023382 (Data Analysis Center), U24OD023319 (Patient reported outcome [PRO] Core), UH3 OD023282 (COAST [Childhood Origins of Asthma], INSPIRE [Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure], URECA [Urban Environment and Childhood Asthma]), and UH3 OD023288 (VCSIP [Vitamin C to Decrease the Effects of Smoking in Pregnancy on Infant Lung Function]) and grants UM1 AI114271, UM1 AI160040, U19 AI62310, UL1 TR002243, P51 OD011092, and R01 HL104608.
Publisher Copyright:
© 2023 The Authors
PY - 2023/6
Y1 - 2023/6
N2 - Background: DNA methylation of cytosines at cytosine-phosphate-guanine (CpG) dinucleotides (CpGs) is a widespread epigenetic mark, but genome-wide variation has been relatively unexplored due to the limited representation of variable CpGs on commercial high-throughput arrays. Objectives: To explore this hidden portion of the epigenome, this study combined whole-genome bisulfite sequencing with in silico evidence of gene regulatory regions to design a custom array of high-value CpGs. This study focused on airway epithelial cells from children with and without allergic asthma because these cells mediate the effects of inhaled microbes, pollution, and allergens on asthma and allergic disease risk. Methods: This study identified differentially methylated regions from whole-genome bisulfite sequencing in nasal epithelial cell DNA from a total of 39 children with and without allergic asthma of both European and African ancestries. This study selected CpGs from differentially methylated regions, previous allergy or asthma epigenome-wide association studies (EWAS), or genome-wide association study loci, and overlapped them with functional annotations for inclusion on a custom Asthma&Allergy array. This study used both the custom and EPIC arrays to perform EWAS of allergic sensitization (AS) in nasal epithelial cell DNA from children in the URECA (Urban Environment and Childhood Asthma) birth cohort and using the custom array in the INSPIRE [Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure] birth cohort. Each CpG on the arrays was assigned to its nearest gene and its promotor capture Hi-C interacting gene and performed expression quantitative trait methylation (eQTM) studies for both sets of genes. Results: Custom array CpGs were enriched for intermediate methylation levels compared to EPIC CpGs. Intermediate methylation CpGs were further enriched among those associated with AS and for eQTMs on both arrays. Conclusions: This study revealed signature features of high-value CpGs and evidence for epigenetic regulation of genes at AS EWAS loci that are robust to race/ethnicity, ascertainment, age, and geography.
AB - Background: DNA methylation of cytosines at cytosine-phosphate-guanine (CpG) dinucleotides (CpGs) is a widespread epigenetic mark, but genome-wide variation has been relatively unexplored due to the limited representation of variable CpGs on commercial high-throughput arrays. Objectives: To explore this hidden portion of the epigenome, this study combined whole-genome bisulfite sequencing with in silico evidence of gene regulatory regions to design a custom array of high-value CpGs. This study focused on airway epithelial cells from children with and without allergic asthma because these cells mediate the effects of inhaled microbes, pollution, and allergens on asthma and allergic disease risk. Methods: This study identified differentially methylated regions from whole-genome bisulfite sequencing in nasal epithelial cell DNA from a total of 39 children with and without allergic asthma of both European and African ancestries. This study selected CpGs from differentially methylated regions, previous allergy or asthma epigenome-wide association studies (EWAS), or genome-wide association study loci, and overlapped them with functional annotations for inclusion on a custom Asthma&Allergy array. This study used both the custom and EPIC arrays to perform EWAS of allergic sensitization (AS) in nasal epithelial cell DNA from children in the URECA (Urban Environment and Childhood Asthma) birth cohort and using the custom array in the INSPIRE [Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure] birth cohort. Each CpG on the arrays was assigned to its nearest gene and its promotor capture Hi-C interacting gene and performed expression quantitative trait methylation (eQTM) studies for both sets of genes. Results: Custom array CpGs were enriched for intermediate methylation levels compared to EPIC CpGs. Intermediate methylation CpGs were further enriched among those associated with AS and for eQTMs on both arrays. Conclusions: This study revealed signature features of high-value CpGs and evidence for epigenetic regulation of genes at AS EWAS loci that are robust to race/ethnicity, ascertainment, age, and geography.
KW - DNA methylation array
KW - EWAS
KW - airway epithelial cells
KW - gene expression
UR - http://www.scopus.com/inward/record.url?scp=85150068919&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2022.12.828
DO - 10.1016/j.jaci.2022.12.828
M3 - Article
C2 - 36754293
AN - SCOPUS:85150068919
SN - 0091-6749
VL - 151
SP - 1609
EP - 1621
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 6
ER -